-
ElectroCore Analyst: Nerve Stimulation Market Opportunity Is Large
Tuesday, July 27, 2021 - 6:03pm | 263A combination of a large total addressable market, regulatory clearance, strong partnerships and effective product has Ladenburg Thalmann analysts bullish on electroCore, Inc. (NASDAQ: ECOR). The electroCore Analyst: Jeffrey Cohen initiated coverage on electroCore with a Buy rating and $3...
-
Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data
Wednesday, December 7, 2016 - 12:43pm | 332The market's bullish response to Neovasc Inc (US) (NASDAQ: NVCN)'s announcement that Boston Scientific Corporation (NYSE: BSX) was set to buy a 15 percent stake in the company was bolstered by a positive data release on Neovasc's Tiara mitral valve. Shares gained 70 percent over the trading day...